Operating
Change in Other Assets
Vertex Pharmaceuticals Change in Other Assets increased by 512.7% to $250.60M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 52.2%, from $164.60M to $250.60M. Over 3 years (FY 2022 to FY 2025), Change in Other Assets shows an upward trend with a 6.7% CAGR.
Analysis
StatementCash Flow Statement
SectionOperating
CategoryEfficiency
SignalContext dependent
VolatilityModerate
First reportedQ4 2013
Last reportedQ4 2025
How to read this metric
Large swings are usually related to the timing of prepayments for services or long-term supply agreements.
Detailed definition
This captures the net change in miscellaneous operating assets not classified as receivables or inventory, such as prepa...
Peer comparison
This is typically a smaller component of cash flow for most large-cap technology firms unless they are securing long-term supply capacity.
Metric ID:
cf_change_in_other_assetsHistorical Data
18 periods
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $78.87M | $15.49M | -$67.60M | -$17.70M | $127.20M | $284.50M | -$46.20M | $19.60M | $121.00M | $451.30M | -$99.20M | $155.90M | -$21.00M | $164.60M | $28.10M | $76.40M | $40.90M | $250.60M |
| QoQ Change | — | -80.4% | -536.6% | +73.8% | +818.6% | +123.7% | -116.2% | +142.4% | +517.3% | +273.0% | -122.0% | +257.2% | -113.5% | +883.8% | -82.9% | +171.9% | -46.5% | +512.7% |
| YoY Change | — | — | — | -122.4% | +721.4% | — | +31.7% | +210.7% | -4.9% | +58.6% | -114.7% | +695.4% | -117.4% | -63.5% | +128.3% | -51.0% | +294.8% | +52.2% |
Range-$99.20M – $451.30M
CAGR+31.3%
Avg YoY Growth+122.8%
Median YoY Growth+42.0%
Change in Other Assets at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's change in other assets?
- Vertex Pharmaceuticals (VRTX) reported change in other assets of $250.60M in Q4 2025.
- How has Vertex Pharmaceuticals's change in other assets changed year-over-year?
- Vertex Pharmaceuticals's change in other assets increased by 52.2% year-over-year, from $164.60M to $250.60M.
- What is the long-term trend for Vertex Pharmaceuticals's change in other assets?
- Over 3 years (2022 to 2025), Vertex Pharmaceuticals's change in other assets has grown at a 6.7% compound annual growth rate (CAGR), from $326.40M to $396.00M.
- What does change in other assets mean?
- The change in various other business assets like prepayments or miscellaneous deposits.